This state atlas resolves DSIP / Emideltide to its fda-flagged unapproved research-market peptide identity first, then connects that identity to 50 official US state pharmacy verification routes. It answers where to check a seller or prescription claim without turning a state license, research listing, or shared ingredient name into a blanket legal, availability, or medical conclusion.
DSIP, also called emideltide or delta sleep-inducing peptide, is tracked here as a US research-market identity. FDA has identified emideltide among bulk substances that may present significant safety risks in compounding and notes important gaps in human safety information. That does not establish an approved medicine, a lawful local supply route, seller identity, product quality, or suitability for use in any destination.
Primary identity source: Read the FDA source / U.S. Food and Drug Administration ↗These answers define what a compound identity and state license record can establish. They are not medical advice, legal advice, seller certification, or an availability finding.
No blanket answer is supportable. Product identity, FDA status, compounding, prescription requirements, pharmacy authority, seller identity, and the actual supply route are separate questions. Choose the state below and verify the exact current record before treating a listing as authorized or available.
No. A state record can help resolve the pharmacy or seller behind a claim, but it does not prove that the pictured vial, ingredient, presentation, batch, prescription route, compounding basis, or delivery claim matches an authorized product or lawful transaction.
Resolve the compound through its primary identity source, verify the pharmacy or seller through the destination state's official record, and then compare only offers with the same product category, presentation, supply route, evidence access, total price, and observation date.
The sequence stays fixed while the responsible state board, database, seller identity, and claimed supply route change.
Open the primary identity record and keep its research-market, clinical-pipeline, or approved-medicine evidence lane attached.
Use the exact state pharmacy or license search below. Match the legal name, address, profession, status, and record date.
A matching seller name is only one step. Verify the product category, presentation, prescription or research route, evidence access, and delivery claim separately.
Each card joins the same resolved compound identity to a different official state verification route and a substantive local guide.
DSIP / Emideltide in Alabama begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alabama, open Board of Pharmacy license lookup from Alabama Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Alaska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Alaska, open Professional license search from Alaska Department of Commerce, Community and Economic Development and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Arizona begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arizona, open License and permit verification from Arizona State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Arkansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Arkansas, open Pharmacy roster search and license verification from Arkansas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Colorado begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Colorado, open Business and professional license lookup from Colorado Department of Regulatory Agencies and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Connecticut begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Connecticut, open eLicense pharmacy lookup from Connecticut Department of Consumer Protection and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Delaware begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Delaware, open DelPROS license lookup from Delaware Division of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Florida begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Florida, open Health license lookup from Florida Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Georgia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Georgia, open Facility license verification from Georgia Secretary of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Hawaii begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Hawaii, open Professional and vocational license search from Hawaii Department of Commerce and Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Idaho begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Idaho, open Division of Occupational and Professional Licenses search from Idaho Division of Occupational and Professional Licenses and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Illinois begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Illinois, open Pharmacy program and license lookup from Illinois Department of Financial and Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Indiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Indiana, open Free Search & Verify from Indiana Professional Licensing Agency and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Iowa begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Iowa, open Board of Pharmacy business lookup from Iowa Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Kansas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kansas, open Board of Pharmacy license portal from Kansas Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Kentucky begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Kentucky, open Board of Pharmacy licensing hub from Kentucky Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Louisiana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Louisiana, open Board of Pharmacy licensing and verification from Louisiana Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Maine begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maine, open Board of Pharmacy licensing and verification from Maine Office of Professional and Occupational Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Maryland begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Maryland, open Board of Pharmacy facility verification from Maryland Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Massachusetts begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Massachusetts, open Health profession license verification from Massachusetts Bureau of Health Professions Licensure and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Michigan begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Michigan, open LARA licensee search from Michigan Department of Licensing and Regulatory Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Minnesota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Minnesota, open Board of Pharmacy entity search from Minnesota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Mississippi begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Mississippi, open Board of Pharmacy license verification from Mississippi Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Missouri begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Missouri, open MOPRO license search from Missouri Division of Professional Registration and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Montana begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Montana, open Public license search from Montana Department of Labor and Industry and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Nebraska begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nebraska, open Health license information search from Nebraska Department of Health and Human Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Nevada begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Nevada, open License verification from Nevada State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in New Hampshire begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Hampshire, open Pharmacy facility license verification from New Hampshire Office of Professional Licensure and Certification and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in New Jersey begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Jersey, open Real-time license verification from New Jersey Division of Consumer Affairs and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in New Mexico begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New Mexico, open Regulation and Licensing public search from New Mexico Regulation and Licensing Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in New York begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving New York, open Online license and establishment verification from New York State Education Department and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in North Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Carolina, open License and permit verification portal from North Carolina Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in North Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving North Dakota, open Board of Pharmacy license verification from North Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Ohio begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Ohio, open Ohio professional and business license look-up from eLicense Ohio and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Oklahoma begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oklahoma, open Board of Pharmacy facility search from Oklahoma State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Oregon begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Oregon, open Board of Pharmacy facility verification from Oregon Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Pennsylvania begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Pennsylvania, open Professional and occupational license verification from Pennsylvania Department of State and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Rhode Island begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Rhode Island, open Health license verification from Rhode Island Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in South Carolina begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Carolina, open Board of Pharmacy license lookup from South Carolina Department of Labor, Licensing and Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in South Dakota begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving South Dakota, open Board of Pharmacy business lookup from South Dakota Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Tennessee begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Tennessee, open Health licensure verification from Tennessee Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Texas begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Texas, open Pharmacy license search from Texas State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Utah begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Utah, open Division of Professional Licensing search from Utah Division of Professional Licensing and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Vermont begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Vermont, open Office of Professional Regulation license lookup from Vermont Office of Professional Regulation and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Virginia, open DHP License Lookup from Virginia Department of Health Professions and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Washington begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Washington, open Provider credential or facility search from Washington State Department of Health and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in West Virginia begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving West Virginia, open Board of Pharmacy public verification from West Virginia Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Wisconsin begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wisconsin, open License search from Wisconsin Department of Safety and Professional Services and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
DSIP / Emideltide in Wyoming begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving Wyoming, open Board of Pharmacy license verification from Wyoming State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.
Use the atlas for a readable state comparison or download the complete compound-state dataset. Each record retains the identity source, state record, supporting official record, review date, and canonical section link.
Download all 2050 compound-state rows →Compare DSIP / Emideltide across 42 countries →Open the DSIP / Emideltide identity record →Browse all country, province, state, region, and city guides →Read the publication standard →